Influenza Vaccination Coverage, Motivators for, and Barriers to Influenza Vaccination among Healthcare Workers in Wroclaw, Poland.

Michał Jacek Jędrzejek, Agnieszka Mastalerz-Migas
Author Information
  1. Michał Jacek Jędrzejek: Department of Family Medicine, Wroclaw Medical University, W. Syrokomli 1, 51-141 Wrocław, Poland. ORCID
  2. Agnieszka Mastalerz-Migas: Department of Family Medicine, Wroclaw Medical University, W. Syrokomli 1, 51-141 Wrocław, Poland. ORCID

Abstract

BACKGROUND: Influenza vaccination, as a key element of control activities intended to prevent nosocomial influenza transmission, is recommended each year for all healthcare workers (HCWs). The objectives were to determine the rate of influenza vaccination and to identify reasons for receiving or declining the influenza vaccine among HCWs in the 2018/19 and 2019/20 influenza seasons.
METHODS: This study is a cross-sectional observational study carried out between January and March 2020, in 2 hospitals and 15 primary health-care settings (PHCS) in Wroclaw (Poland).
RESULTS: A total of 165 questionnaires were completed. The majority of participating HCWs were female-137 (83.0%), and, by profession, the majority were physicians 92 (55.8%). Influenza vaccination coverage was 61.2% in 2019/20, and 47.9% in the 2018/19 season for all participants. Participants who were male, physicians and personnel from PHCS were more frequently vaccinated in both seasons. According to the statistical analysis, physicians were more likely to receive vaccinations than nurses ( < 0.01), as were HCWs who had been vaccinated in the previous season ( < 0.001).
CONCLUSION: The identified barriers were mainly caused by misconceptions (fear of vaccine adverse effects and perception of not being at risk/no need to get vaccinated) and an organizational barriers (lack of time). These findings may prove useful for designing immunization campaigns to tailor strategies to reach specific groups.

Keywords

References

  1. Public Health. 2018 Jan;154:102-109 [PMID: 29220709]
  2. BMC Health Serv Res. 2018 Nov 14;18(1):853 [PMID: 30428886]
  3. Influenza Other Respir Viruses. 2011 Nov;5(6):382-8 [PMID: 21668685]
  4. J Hosp Infect. 2017 Jul;96(3):268-275 [PMID: 28283372]
  5. Hum Vaccin Immunother. 2020;16(2):321-326 [PMID: 31526228]
  6. Vaccine. 2009 Jun 19;27(30):3935-44 [PMID: 19467744]
  7. BMC Public Health. 2008 Dec 23;8:422 [PMID: 19105838]
  8. J Hosp Infect. 2012 Apr;80(4):316-20 [PMID: 22336083]
  9. Electron Physician. 2018 Aug 25;10(8):7217-7223 [PMID: 30214704]
  10. PLoS One. 2013 Nov 18;8(11):e81200 [PMID: 24260560]
  11. PLoS One. 2020 May 1;15(5):e0232722 [PMID: 32357190]
  12. Vaccine. 2008 Nov 5;26(47):5918-21 [PMID: 18804133]
  13. Adv Exp Med Biol. 2020;1251:115-121 [PMID: 31989546]
  14. J Hosp Infect. 2011 Apr;77(4):327-31 [PMID: 21316803]
  15. Wkly Epidemiol Rec. 2012 Nov 23;87(47):461-76 [PMID: 23210147]
  16. Med Pr. 2009;60(5):369-76 [PMID: 19999040]
  17. Vaccine. 2011 Aug 11;29(35):5963-9 [PMID: 21699950]
  18. Infect Control Hosp Epidemiol. 2006 Jun;27(6):612-7 [PMID: 16755482]
  19. Am J Infect Control. 2016 Mar 1;44(3):361-2 [PMID: 26577627]
  20. Vaccine X. 2019 Jul 11;2:100036 [PMID: 31384750]
  21. BMC Nurs. 2017 Apr 28;16:20 [PMID: 28465672]
  22. Infect Control Hosp Epidemiol. 2007 Feb;28(2):171-7 [PMID: 17265398]
  23. BMC Health Serv Res. 2017 Nov 15;17(1):732 [PMID: 29141619]
  24. Vaccine. 2009 Sep 4;27(40):5538-41 [PMID: 19651170]
  25. Infection. 2006 Jun;34(3):142-7 [PMID: 16804657]
  26. BMJ Open. 2016 Sep 13;6(9):e012149 [PMID: 27625062]
  27. Open Forum Infect Dis. 2019 Apr 17;6(4):ofz096 [PMID: 31012441]
  28. Vaccine. 2018 Mar 27;36(14):1804-1807 [PMID: 29503114]
  29. Vaccine. 2010 Jun 11;28(26):4283-7 [PMID: 20441803]
  30. Lancet. 2000 Jan 8;355(9198):93-7 [PMID: 10675165]
  31. Hum Vaccin Immunother. 2018 Mar 4;14(3):772-789 [PMID: 28787234]
  32. J Hosp Infect. 2016 Oct;94(2):133-42 [PMID: 27546456]
  33. PLoS One. 2012;7(7):e39496 [PMID: 22808039]
  34. Clin Infect Dis. 2014 Jan;58(1):50-7 [PMID: 24046301]
  35. Am J Infect Control. 2017 May 1;45(5):575-578 [PMID: 27665029]
  36. Influenza Other Respir Viruses. 2018 May;12(3):319-325 [PMID: 29430860]
  37. MMWR Recomm Rep. 2019 Aug 23;68(3):1-21 [PMID: 31441906]
  38. Pediatr Infect Dis J. 1999 Sep;18(9):779-83 [PMID: 10493337]
  39. Vaccine. 2010 Aug 23;28(37):5931-3 [PMID: 20637760]
  40. Isr J Health Policy Res. 2016 Oct 26;5:52 [PMID: 27800154]
  41. Vaccine. 2017 Jan 5;35(2):205-207 [PMID: 27919630]
  42. Vaccine. 2018 May 31;36(23):3351-3358 [PMID: 29716777]
  43. Vaccine. 2008 May 12;26(20):2482-9 [PMID: 18407385]
  44. Int J Med Sci. 2010 Sep 21;7(5):319-25 [PMID: 20922053]
  45. Infect Control Hosp Epidemiol. 2006 Nov;27(11):1278-80 [PMID: 17080394]
  46. Infection. 2009 Jun;37(3):197-202 [PMID: 19139807]

MeSH Term

Attitude of Health Personnel
Cross-Sectional Studies
Female
Health Personnel
Humans
Influenza Vaccines
Influenza, Human
Male
Poland
Surveys and Questionnaires
Vaccination
Vaccination Coverage

Chemicals

Influenza Vaccines

Word Cloud

Created with Highcharts 10.0.0influenzavaccineInfluenzaHCWsvaccinationphysiciansvaccinatedhealthcareworkersamong2018/192019/20seasonsstudyPHCSWroclawPolandmajoritycoverageseason<0barriersVaccinationBACKGROUND:keyelementcontrolactivitiesintendedpreventnosocomialtransmissionrecommendedyearobjectivesdeterminerateidentifyreasonsreceivingdecliningMETHODS:cross-sectionalobservationalcarriedJanuaryMarch20202hospitals15primaryhealth-caresettingsRESULTS:total165questionnairescompletedparticipatingfemale-137830%profession92558%612%479%participantsParticipantsmalepersonnelfrequentlyAccordingstatisticalanalysislikelyreceivevaccinationsnurses01previous001CONCLUSION:identifiedmainlycausedmisconceptionsfearadverseeffectsperceptionrisk/noneedgetorganizationallacktimefindingsmayproveusefuldesigningimmunizationcampaignstailorstrategiesreachspecificgroupsCoverageMotivatorsBarriersHealthcareWorkershesitancyobjections

Similar Articles

Cited By